DiaMedica Therapeutics Inc.
DMAC
$8.51
$0.536.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -47.09% | -48.63% | -40.19% | -26.12% | -20.78% |
| Total Depreciation and Amortization | 19.44% | 2.94% | 35.48% | 30.00% | 28.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 256.50% | 288.79% | 167.65% | 54.15% | -10.53% |
| Change in Net Operating Assets | 17.85% | 701.67% | 303.13% | 1,525.81% | 440.35% |
| Cash from Operations | -42.55% | -29.67% | -11.24% | -17.88% | -10.02% |
| Capital Expenditure | -95.24% | -54.55% | -7.69% | -4.17% | 60.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -151.99% | -6.47% | 166.41% | 147.00% | 148.38% |
| Cash from Investing | -152.54% | -6.55% | 166.13% | 146.80% | 148.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -57.14% | -83.33% | -83.33% | -50.00% | -16.67% |
| Issuance of Common Stock | 172.49% | -95.70% | -67.17% | -67.43% | -67.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 168.72% | -95.79% | -67.20% | -67.44% | -67.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -142.48% | -221.03% | 1,084.00% | -720.54% | 452.88% |